Kalaora, S., Nagler, A., Wargo, J. A. & Samuels, Y. Mechanisms of immune activation and regulation: lessons from melanoma. Nat. Rev. Cancer 22, 195–207 (2022).

Article  CAS  PubMed  Google Scholar 

Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolchok, J. D. et al. Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma. N. Engl. J. Med. 392, 11–22 (2024).

Herrscher, H. & Robert, C. Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting. Curr. Opin. Oncol. 32, 106–113 (2020).

Article  CAS  PubMed  Google Scholar 

Atkins, M. B. et al. The state of melanoma: emergent challenges and opportunities. Clin. Cancer Res. 27, 2678–2697 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shain, A. H. & Bastian, B. C. From melanocytes to melanomas. Nat. Rev. Cancer 16, 345–358 (2016).

Article  CAS  PubMed  Google Scholar 

Cerezo-Wallis, D. & Soengas, M. S. Understanding tumor–antigen presentation in the new era of cancer immunotherapy. Curr. Pharm. Des. 22, 6234–6250 (2016).

Article  CAS  PubMed  Google Scholar 

Grasso, C. S. et al. Conserved interferon-γ signaling drives clinical response to immune checkpoint blockade therapy in melanoma. Cancer Cell 39, 500–515 (2021).

Article  Google Scholar 

Olmeda, D. et al. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature 546, 676–680 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cerezo-Wallis, D. et al. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state. Nat. Med. 26, 1865–1877 (2020).

Article  CAS  PubMed  Google Scholar 

Neumaier, E. E., Rothhammer, V. & Linnerbauer, M. The role of midkine in health and disease. Front. Immunol. 14, 1310094 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Filippou, P. S., Karagiannis, G. S. & Constantinidou, A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene 39, 2040–2054 (2020).

Article  CAS  PubMed  Google Scholar 

Zhao, S. et al. Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity. Cancer Immunol. Immunother. 61, 1745–1753 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang, Y., Kwiatkowski, D. J. & Henske, E. P. Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment. Nat. Commun. 13, 5018 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sorrelle, N., Dominguez, A. T. A. & Brekken, R. A. From top to bottom: midkine and pleiotrophin as emerging players in immune regulation. J. Leukoc. Biol. 102, 277–286 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heras-Murillo, I., Adan-Barrientos, I., Galan, M., Wculek, S. K. & Sancho, D. Dendritic cells as orchestrators of anticancer immunity and immunotherapy. Nat. Rev. Clin. Oncol. 21, 257–277 (2024).

Article  PubMed  Google Scholar 

Marciscano, A. E. & Anandasabapathy, N. The role of dendritic cells in cancer and anti-tumor immunity. Semin. Immunol. 52, 101481 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maier, B. et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature 580, 257–262 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gerhard, G. M., Bill, R., Messemaker, M., Klein, A. M. & Pittet, M. J. Tumor-infiltrating dendritic cell states are conserved across solid human cancers. J. Exp. Med. 218, e20200264 (2021).

Article  CAS  PubMed  Google Scholar 

Nirschl, C. J. et al. IFNγ-dependent tissue-immune homeostasis is co-opted in the tumor microenvironment. Cell 170, 127–141 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ardouin, L. et al. Broad and largely concordant molecular changes characterize tolerogenic and immunogenic dendritic cell maturation in thymus and periphery. Immunity 45, 305–318 (2016).

Article  CAS  PubMed  Google Scholar 

Bayerl, F. et al. Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses. Immunity 56, 1341–1358 (2023).

Article  CAS  PubMed  Google Scholar 

Jin, P. et al. Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies. J. Transl. Med. 8, 4 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Brasel, K., De Smedt, T., Smith, J. L. & Maliszewski, C. R. Generation of murine dendritic cells from FLT3-ligand-supplemented bone marrow cultures. Blood 96, 3029–3039 (2000).

Article  CAS  PubMed  Google Scholar 

Meeth, K., Wang, J. X., Micevic, G., Damsky, W. & Bosenberg, M. W. The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations. Pigment Cell Melanoma Res. 29, 590–597 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy, T. L. & Murphy, K. M. Dendritic cells in cancer immunology. Cell. Mol. Immunol. 19, 3–13 (2022).

Article  CAS  PubMed  Google Scholar 

Hildner, K. et al. BATF3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097–1100 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7–24 (2020).

Article  CAS  PubMed  Google Scholar 

Spranger, S., Dai, D., Horton, B. & Gajewski, T. F. Tumor-residing BATF3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell 31, 711–723 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bottcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022–1037 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Broz, M. L. et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 26, 638–652 (2014).

Article  CAS  PubMed  PubMed Ce